Training Hematology and Oncology Fellows in Clinical Research

培训血液学和肿瘤学研究员进行临床研究

• 批准号: 10434663
• 负责人: Claire F. Verschraegen
• 金额: $ 16.45万
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-07-01 至 2025-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10434663
• 关键词: Clinical Research; Hematology; Oncology; Training

PROJECT SUMMARY The objective of this Ohio State University postdoctoral clinical T32 training program entitled: “Training Hematology and Oncology Fellows in Clinical Research” is to provide a state of the art clinical research training experience, specifically for postdoctoral fellows in Hematology and Oncology with an M.D., D.O., or equivalent degree who have demonstrated a firm commitment to patient oriented cancer research. The overriding goal of this training program is to prepare Hematology and Oncology fellows in the OSU Divisions of Hematology and Medical Oncology for academic careers in patient oriented clinical and translational cancer investigation. Progress in cancer therapy and prevention requires strong collaborative efforts, and patient oriented physician investigators provide a critical link with physician-scientists and basic scientists toward this goal. The recent explosive growth of scientific discoveries and the increasing complexity of cancer clinical trials, particularly phase I/II studies of novel therapeutic agents and regimens, make it imperative that trainees in Hematology/Oncology acquire the proper training through appropriate mentoring, to prepare them for careers in clinical and translational investigation. This T32 program will prepare fellowship trainees for productive academic careers by providing an intellectually rigorous curriculum, strong mentoring and support from senior faculty, protected time for academic training during fellowship, “hands on” experience in developing and writing clinical studies and research papers, and ample opportunities to enhance their OSU experience with extramural programs and workshops sponsored by the NCI or other professional academic organizations such as ASCO and ASH. The participating members consist of the 2 Program Directors, Coordinating Committee members, Advisory Committee members, primary mentors, and contributing faculty, who were chosen based on their prior track record of successful mentoring and their demonstrated commitment to clinical and translational research. T32 fellows will commit for two years of training. The strengths of the OSUCCC, primarily in the fields of cancer prevention and experimental therapeutics, is the perfect environment to our planned success. Our T32 proposal is designed to foster and ensure the development of fellowship trainees, who we will train to assume academic clinical research positions as faculty members upon graduation. The T32 program is engineered to empower trainees to become independent clinical and translational investigators. Trainees will have mandatory an elective training in various settings, including the opportunity to obtain one or two master degrees; they will be required to create an investigator initiated clinical study and will start its implementation during training; they will be required to apply for funding for their own study through peer reviewed grant mechanisms; and they will be offered the opportunity to network nationally with the NCI and oncology professional organizations. OSUCCC is also deeply committed to training women and members of underrepresented racial and ethnic groups for academic careers as shown in continuous efforts to recruit and train female and underrepresented minority fellows.

项目摘要 俄亥俄州立大学博士后临床T32培训计划的目的：“培训 临床研究中的血液学和肿瘤学研究员”是为了提供最先进的临床研究培训 经验，专门用于血液学和肿瘤学博士学位的经验， 表现出对以患者为导向的癌症研究的坚定承诺的学位。覆盖目标 该培训计划是为血液学和血液学分区中的血液学和肿瘤学研究员准备 针对患者临床和翻译癌症调查的学术职业的医学肿瘤学。 癌症治疗和预防的进展需要大量的协作努力，并以患者为导向的医生 调查人员与身体科学家和基本科学家为此目标提供了关键的联系。最近 科学发现的爆炸性增长和癌症临床试验的复杂性的增加，尤其是阶段 I/II的新型热剂和方案的研究，必须使学员血液学/肿瘤学学员必须 通过适当的心理获得适当的培训，为临床和翻译的职业做好准备 投资。该T32计划将通过提供产品学术职业的奖学金学员 智力上严格的课程，高级教师的强烈心理和支持，保护学术时间 奖学金期间的培训，在开发和撰写临床研究和研究论文方面的“动手”经验， 并有足够的机会通过赞助的壁外计划和讲习班来增强其OSU体验 由NCI或其他专业的学术组织，例如ASCO和ASH。参与成员 由两位计划董事，协调委员会成员，咨询委员会成员，小学组成 导师和贡献教师，他们是根据成功指导的先前记录来选择的 他们表现出对临床和翻译研究的承诺。 T32研究员将承诺两年 训练。 OSUCCC的优势，主要在预防癌症和实验领域 治疗方法是我们计划成功的完美环境。我们的T32提案旨在促进和 确保奖学金培训的发展，我们将培训他担任学术临床研究职位 作为毕业后的教师。 T32计划设计为授权受训者成为 独立的临床和翻译研究人员。学员将在各种方面进行选修课 设置，包括获得一个或两个硕士学位的机会；他们将被要求创建一个 研究人员开始临床研究，并将在培训期间开始实施；他们将被要求申请 通过同行审查的赠款机制为自己的研究提供资金；他们将获得机会 与NCI和肿瘤学专业组织在全国范围内联网。 OSUCCC也非常投入 培训妇女和代表性不足的赛车和种族成员的学术职业，如图所示 不断努力招募和培训女性和代表性不足的少数群体。